Watch the demo
Includes Powerful New In Silico Models and First-to-Market Software Capabilities
Read the news
Haisco Pharmaceutical Group Strengthens Drug Discovery Processeswith Instem’s
KnowledgeScan™ Target Safety Assessment Service
Download the Case Study
Join the journey with us by visiting one of our bi-weekly industry Blogs
Acquisition of PDS Life Sciences Consolidates Non-Clinical Market; Further Extends Instem’s Leadership in Study Management and Regulatory SEND Submission Support
Powerful New In Silico Models and First-to-Market Software Capabilities to Deliver Further Efficiencies and Increased Regulatory Compliance
Instem’s Acquisition of Leading Clinical Trial Technology and Consulting Provider d-wise Represents Substantial Advancement of its Mission
To help you better evaluate our software or services, we believe an initial, no pressure Web session is the way to go.
We are excited that you have decided to take the next step with Instem. To provide you with an accurate quotation, we ask that you fill out our form.
© 2021 Instem Group of Companies